Do Canine Pancreatic Neuroendocrine Neoplasms Resemble Human Pancreatic Neuroendocrine Tumours? A Comparative Morphological and Immunohistochemical Investigation
Antibodies Assay Kits Biology Cells cDNA Clia Kits Culture Cells Devices DNA DNA Templates DNA Testing Elisa Kits Enzymes Equipments Exosomes Gels Isotypes Medium & Serums NATtrol Panel Particles PCR Pcr Kits Peptides Reagents Recombinant Proteins Ria Kits RNA Test Kits Vector & Virus Western Blot
December 9, 2020

Do Canine Pancreatic Neuroendocrine Neoplasms Resemble Human Pancreatic Neuroendocrine Tumours? A Comparative Morphological and Immunohistochemical Investigation

By Matsuoka

Though canine pancreatic neuroendocrine neoplasms (PanNENs) have been proposed as a mannequin for the counterpart human neoplasms, the kind or grade of human PanNEN that they resemble is unclear. PanNENs in animals are categorised as adenoma or carcinoma, whereas in people they’re categorised as pancreatic neuroendocrine tumour (PanNET) if well-differentiated, or as pancreatic neuroendocrine carcinoma (PanNEC) if poorly differentiated.

We evaluated 16 canine main PanNENs and two metastases histologically and immunohistochemically, and graded them utilizing the animal and human grading techniques. All neoplasms had native or vascular invasion and had been categorised as pancreatic islet cell carcinomas in accordance with the present WHO classification. The Ki-67 index was low in all instances (0.01-1.50%). All had cytoplasmic expression of synaptophysin and insulin however had been immunonegative for glucagon, confirming a purposeful analysis of canine insulinoma. Membranous expression of SSTR2A and nuclear expression of ATRX, however no p53 expression, was present in all neoplasms.

One main tumour was recognized as a combined neuroendocrine-non-neuroendocrine neoplasm, which is the primary report of this neoplasm in canines. The opposite 15 main tumours and each metastatic tumours had been graded as PanNET G1, in accordance with the human WHO classification. We conclude that canine PanNENs share well-differentiated histomorphology, SSTR2A expression and absence of nuclear p53 immunolabelling with human PanNETs G1. Nevertheless, they differ in ATRX gene expression and performance, and appear to have a worse prognosis than human PanNETs G1, though their typically low Ki-67 index precludes extra exact evaluation of prognosis. Membranous SSTR2A expression renders canine PanNENs doubtlessly amenable to remedy with somatostatin analogues or SSTR focused in-vivo imaging strategies.

Gene Augmentation and Enhancing to Enhance TCR Engineered T Cell Remedy in opposition to Stable Tumors

Latest developments in gene engineering applied sciences have drastically improved the therapeutic remedy choices for most cancers sufferers. The usage of efficient chimeric antigen receptor T (CAR-T) cells and recombinant T cell receptor engineered T (rTCR-T) cells has entered the clinic for remedy of hematological malignancies with promising outcomes. Nevertheless, additional fine-tuning, to enhance performance and security, is important to use these methods for the remedy of strong tumors. The immunosuppressive microenvironment, the encompassing stroma, and the tumor heterogeneity usually leads to poor T cell reactivity, performance, and a diminished infiltration charges, hampering the efficacy of the remedy.
The main focus of this assessment is on current advances in rTCR-T cell remedy, to enhance each performance and security, for potential remedy of strong tumors and offers an summary of ongoing scientific trials. In addition to collection of the suitable tumor related antigen, environment friendly supply of an optimized recombinant TCR transgene into the T cells, together with gene modifying methods eliminating the endogenous TCR expression and disrupting particular inhibitory pathways may enhance adoptively transferred T cells. Armoring the rTCR-T cells with particular cytokines and/or chemokines and their receptors, or concentrating on the tumor stroma, can improve the infiltration price of the immune cells inside the strong tumors.
Alternatively, scientific “off-tumor/on-target” toxicities are nonetheless a significant potential threat and might result in extreme antagonistic occasions. Incorporation of security switches in rTCR-T cells can assure further security. Latest scientific trials present encouraging knowledge and emphasize the relevance of gene remedy and gene modifying instruments for potential remedy of strong tumors.
Do Canine Pancreatic Neuroendocrine Neoplasms Resemble Human Pancreatic Neuroendocrine Tumours? A Comparative Morphological and Immunohistochemical Investigation

Do Canine Pancreatic Neuroendocrine Neoplasms Resemble Human Pancreatic Neuroendocrine Tumours? A Comparative Morphological and Immunohistochemical Investigation

Lengthy-term oncological outcomes of laparoscopic gastrectomy for grossly early gastric most cancers-mimicking superior gastric most cancers: Propensity rating matching evaluation

Laparoscopic gastrectomy grew to become an choice within the remedy of early gastric most cancers (EGC) in scientific observe. Nevertheless, whether or not laparoscopic surgical procedure for grossly EGC-mimicking superior gastric most cancers (AGC) sufferers is oncologically secure long-term remains to be controversial.We retrospectively analyzed 472 sufferers with AGC who had been recognized as scientific EGC. Sufferers acquired laparoscopic or open gastrectomy with customary lymph node (LN) dissection from January 2007 to February 2015. We used a 1:Three propensity rating matching technique for the evaluation. The matching elements had been age, intercourse, physique mass index, American Society of Anesthesiologists rating and pathologic stage.
After the matching course of, we evaluated the 5-year general survival and the cumulative incidence curve of recurrence.The entire analyzed sufferers had been pathologically recognized with AGC after surgical procedure (grossly EGC-mimicking AGC). The median (vary) period of follow-up was 58.0 (0-132) months. After propensity rating matching, 31.5% of sufferers within the laparoscopy group had D1+ LN dissection and 99.2% of sufferers within the open group had D2 LN dissection. The 5-year general survival price between the laparoscopy (n = 92) and open teams (n = 244) weren’t considerably totally different.

Rat Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E02O0334-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Rat Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E02O0334-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Rat Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E02O0334-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Rat Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E07O0334-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Porcine Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E07O0334-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Porcine Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E07O0334-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Porcine Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E06O0334-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Goat Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E06O0334-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Goat Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E06O0334-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Goat Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E03O0334-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Mouse Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E03O0334-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Mouse Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E03O0334-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Mouse Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E01O0338-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E01O0338-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Human Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E01O0338-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E04O0334--192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Rabbit Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E04O0334--48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Rabbit Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E04O0334--96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Rabbit Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E09O0334-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Monkey Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E09O0334-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Monkey Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E09O0334-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Monkey Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human ovarian cancer antigenX1,OVX1 ELISA Kit
201-12-2137 96 tests
EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human ovarian cancer antigenX1(OVX1)ELISA Kit
QY-E02223 96T
EUR 480

Human ovarian cancer antigenX1,OVX1 ELISA Kit
YLA2932HU-48T 48T
EUR 435

Human ovarian cancer antigenX1,OVX1 ELISA Kit
YLA2932HU-96T 96T
EUR 562.5

Guinea pig Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E05O0334-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Guinea pig Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Guinea pig Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E05O0334-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Guinea pig Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Guinea pig Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E05O0334-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Guinea pig Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Antibody
20-abx173927
  • EUR 1111.20
  • EUR 560.40
  • 1 mg
  • 200 ug

Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Antibody
20-abx129287
  • EUR 543.60
  • EUR 159.60
  • EUR 1579.20
  • EUR 744.00
  • EUR 410.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Antibody
20-abx339623
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Recombinant Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2)
4-RPR870Hu01
  • EUR 603.84
  • EUR 285.60
  • EUR 1934.40
  • EUR 724.80
  • EUR 1329.60
  • EUR 480.00
  • EUR 4656.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 expressed in: E.coli

Ovarian cancer tissue array
OV0071a each
EUR 42
Description: Ovarian cancer tissue array, including TNM/Stage (AJCC 8th edition), 7cases/7 cores (core size 1.5mm)

Ovarian cancer tissue array
OV484b each
EUR 270
Description: Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replacing OV484a

Ovarian cancer tissue array
OV801b each
EUR 270
Description: Ovarian cancer tissue array, with matched (B7/F7, B8/F8, C3/F3) or unmatched adjacent tissue array, 80 cases/80 cores, replacing OV801

Ovarian cancer tissue array
T111a each
EUR 48
Description: Ovarian cancer tissue array, with normal ovary tissue, including TNM and pathology grade, 6 cases/24 cores(1.5mm), replacing T111

Ovarian cancer tissue array
T114a each
EUR 48
Description: Ovarian cancer tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T114

Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Protein
20-abx167980
  • EUR 844.80
  • EUR 343.20
  • EUR 2598.00
  • EUR 994.80
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit
DLR-OCIAD2-Hu-48T 48T
EUR 664.8
Description: A sandwich quantitative ELISA assay kit for detection of Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) in samples from tissue homogenates, cell lysates or other biological fluids.

Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit
DLR-OCIAD2-Hu-96T 96T
EUR 870
Description: A sandwich quantitative ELISA assay kit for detection of Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) in samples from tissue homogenates, cell lysates or other biological fluids.

Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit
RD-OCIAD2-Hu-48Tests 48 Tests
EUR 675.6

Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit
RD-OCIAD2-Hu-96Tests 96 Tests
EUR 939.6

Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit
RDR-OCIAD2-Hu-48Tests 48 Tests
EUR 706.8

Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit
RDR-OCIAD2-Hu-96Tests 96 Tests
EUR 984

Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit
SER870Hu-10x96wellstestplate 10x96-wells test plate
EUR 6227.58
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) in Tissue homogenates, cell lysates and other biological fluids.

Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit
SER870Hu-1x48wellstestplate 1x48-wells test plate
EUR 618.04
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) in Tissue homogenates, cell lysates and other biological fluids.

Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit
SER870Hu-1x96wellstestplate 1x96-wells test plate
EUR 831.48
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) in Tissue homogenates, cell lysates and other biological fluids.

Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit
SER870Hu-5x96wellstestplate 5x96-wells test plate
EUR 3381.66
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) in Tissue homogenates, cell lysates and other biological fluids.

Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit
4-SER870Hu
  • EUR 6288.00
  • EUR 3322.80
  • EUR 831.60
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) in samples from Tissue homogenates, cell lysates and other biological fluids. with no significant corss-reactivity with analogues from other species.

ELISA kit for Human OCIAD2 (Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2)
ELK6833 1 plate of 96 wells
EUR 518.4
Description: A sandwich ELISA kit for detection of Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Human Ovarian Cancer Primer Library
HOVCL-I 1 set
EUR 657.6

Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Polyclonal Antibody (Human)
4-PAR870Hu01
  • EUR 314.40
  • EUR 3296.40
  • EUR 814.80
  • EUR 397.20
  • EUR 264.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2)

Ovarian cancer with ovary tissue array
OV1004a each
EUR 306
Description: Ovarian cancer with ovary tissue array, including high grade serous carcinoma, mixed carcinoma and clear cell carcinoma, mucinous carcinoma, endometrioid carcinoma, pathology grade, TNM and clinical stage (AJCC 8.0), 50 cases/100 cores (core size 1.5mm), replacing OV1004

Ovarian cancer with ovary tissue array
OV1501b each
EUR 306
Description: Ovarian cancer with ovary tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing OV1501a

Ovarian cancer with ovary tissue array
OV2071 each
EUR 546
Description: Ovarian cancer with ovary tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 69 cases/207 cores (1.5mm), replacing OV2083

Ovarian cancer with ovary tissue array
OV809b each
EUR 306
Description: Ovarian cancer with ovary tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing OV809a

Ovarian cancer with ovary tissue array
T112d each
EUR 48
Description: Ovarian cancer with ovary tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T112c

Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Polyclonal Antibody (Human), APC
4-PAR870Hu01-APC
  • EUR 441.60
  • EUR 4318.80
  • EUR 1191.60
  • EUR 566.40
  • EUR 274.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2). This antibody is labeled with APC.

Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Polyclonal Antibody (Human), Cy3
4-PAR870Hu01-Cy3
  • EUR 538.80
  • EUR 5708.40
  • EUR 1539.60
  • EUR 705.60
  • EUR 316.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2). This antibody is labeled with Cy3.

Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Polyclonal Antibody (Human), HRP
4-PAR870Hu01-HRP
  • EUR 402.00
  • EUR 3762.00
  • EUR 1052.40
  • EUR 511.20
  • EUR 258.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2). This antibody is labeled with HRP.

Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Polyclonal Antibody (Human), PE
4-PAR870Hu01-PE
  • EUR 376.80
  • EUR 3478.80
  • EUR 976.80
  • EUR 476.40
  • EUR 243.60
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2). This antibody is labeled with PE.

Ovarian cancer and normal tissue array
OV721 each
EUR 306
Description: Ovarian cancer and normal tissue array, with grade and stage data, 24 cases/72 cores

Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Polyclonal Antibody (Human), FITC
4-PAR870Hu01-FITC
  • EUR 376.80
  • EUR 3478.80
  • EUR 976.80
  • EUR 476.40
  • EUR 243.60
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2). This antibody is labeled with FITC.

Ovarian cancer tissue array (2 of 4)
OV20811a each
EUR 546
Description: Ovarian cancer tissue array (2 of 4), including pathology grade, TNM and clinical stage, 208 cases/208 cores, replacing OV20811

Ovarian cancer tissue array (3 of 4)
OV20812 each
EUR 546
Description: Ovarian cancer tissue array (3 of 4), including TNM and pathology grade, 208 cases/208 cores

Ovarian cancer tissue array (3 of 4)
OV20812a each
EUR 546
Description: Ovarian cancer tissue array (3 of 4), including TNM and pathology grade, 208 cases/208 cores (core size 1.0mm), replacing OV20812

Ovarian cancer tissue array (4 of 4)
OV20813a each
EUR 546
Description: Ovarian cancer tissue array (4 of 4), including TNM and pathology grade, 208 cases/208 cores,replacing by OV20813

Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Polyclonal Antibody (Human), APC-Cy7
4-PAR870Hu01-APC-Cy7
  • EUR 739.20
  • EUR 8493.60
  • EUR 2240.40
  • EUR 988.80
  • EUR 405.60
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2). This antibody is labeled with APC-Cy7.

Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Polyclonal Antibody (Human), Biotinylated
4-PAR870Hu01-Biotin
  • EUR 393.60
  • EUR 3236.40
  • EUR 943.20
  • EUR 484.80
  • EUR 271.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2). This antibody is labeled with Biotin.

Ovarian cancer with normal ovary tissue array
T113c each
EUR 48
Description: Ovarian cancer with normal ovary tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 2 serial sections, 6 cases/24 cores (core size 1.5mm), replacing T113b

Ovarian cancer tissue array for antibody screening
OV1003 each
EUR 306
Description: Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases/100 cores

Ovarian cancer tissue array for antibody screening
OV1004 each
EUR 306
Description: Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases/100 cores

Rat Ovarian cancer marker-CA125 ELISA Kit
ERO0345 96Tests
EUR 625.2

Rat ovarian cancer marker-CA125 ELISA Kit
GA-E0455RT-48T 48T
EUR 380.4

Rat ovarian cancer marker-CA125 ELISA Kit
GA-E0455RT-96T 96T
EUR 595.2

Rat ovarian cancer marker-CA125 ELISA Kit
QY-E11197 96T
EUR 433.2

Goat Ovarian cancer marker-CA125 ELISA Kit
EGTO0345 96Tests
EUR 625.2

Human ovarian cancer marker-CA125 ELISA Kit
201-12-1663 96 tests
EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Mouse ovarian cancer marker-CA125 ELISA Kit
CN-02753M1 96T
EUR 580.8

Mouse ovarian cancer marker-CA125 ELISA Kit
CN-02753M2 48T
EUR 402

Human ovarian cancer marker-CA125 ELISA Kit
GA-E1679HM-48T 48T
EUR 346.8

Human ovarian cancer marker-CA125 ELISA Kit
GA-E1679HM-96T 96T
EUR 559.2

Mouse Ovarian cancer marker-CA125 ELISA Kit
EMO0345 96Tests
EUR 625.2

Human Ovarian cancer marker-CA125 ELISA Kit
EHO0345 96Tests
EUR 625.2

Mouse ovarian cancer marker-CA125 ELISA Kit
GA-E0540MS-48T 48T
EUR 403.2

Mouse ovarian cancer marker-CA125 ELISA Kit
GA-E0540MS-96T 96T
EUR 640.8

Human ovarian cancer marker-CA125 ELISA Kit
QY-E02224 96T
EUR 480

Mouse ovarian cancer marker-CA125 ELISA Kit
QY-E21127 96T
EUR 433.2

Mouse ovarian cancer marker-CA125 ELISA Kit
YLA0894MO-48T 48T
EUR 465

Mouse ovarian cancer marker-CA125 ELISA Kit
YLA0894MO-96T 96T
EUR 600

Canine Ovarian cancer marker-CA125 ELISA Kit
ECO0345 96Tests
EUR 625.2

Rabbit Ovarian cancer marker-CA125 ELISA Kit
ERTO0345 96Tests
EUR 625.2

Bovine Ovarian cancer marker-CA125 ELISA Kit
EBO0345 96Tests
EUR 625.2

Ovarian cancer survey tissue array (1 of 5)
OV2085 each
EUR 474
Description: Ovarian cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores

Ovarian cancer survey tissue array (4 of 5)
OV2088 each
EUR 474
Description: Ovarian cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores

Ovarian cancer survey tissue array (5 of 5)
OV2089 each
EUR 474
Description: Ovarian cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores

Porcine Ovarian cancer marker-CA125 ELISA Kit
EPO0345 96Tests
EUR 625.2

Anserini Ovarian cancer marker-CA125 ELISA Kit
EAO0345 96Tests
EUR 625.2

Ovarian cancer tissue array (2003 WHO classification)
OV803d each
EUR 306
Description: Ovarian cancer tissue array (2003 WHO classification), including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing OV803c

Human Cancer PrimaCell12: Ovarian Tumor Cells
2-96035 1 Kit Ask for price

Ovarian cancer tissue array with normal ovary tissue
OV483a each
EUR 198
Description: Ovarian cancer tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replacing OV483

Rat ovarian cancer marker-CA125(CA125)ELISA Kit
YLA0021RA-48T 48T
EUR 465

Rat ovarian cancer marker-CA125(CA125)ELISA Kit
YLA0021RA-96T 96T
EUR 600

High-density ovarian cancer with ovary tissue array
OV2084b each
EUR 546
Description: High-density ovarian cancer with ovary tissue array, including pathology grade, TNM and clinical stage, 208 cases/208 cores, replacing OV2084a

Ovarian cancer and normal adjacent ovary tissue array
OV701a each
EUR 258
Description: Ovarian cancer and normal adjacent ovary tissue array, including TNM, clinical stage and pathology grade, 70 cases/70 cores(1.5), replacing OV701

Guinea Pig Ovarian cancer marker-CA125 ELISA Kit
EGO0345 96Tests
EUR 625.2

Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody
abx216976-100ug 100 ug
EUR 526.8

Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody
20-abx113889
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody
20-abx322829
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody
20-abx013727
  • EUR 376.80
  • EUR 117.60
  • EUR 477.60
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody
abx430563-200ul 200 ul
EUR 343.2

Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody
20-abx110007
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody
20-abx121442
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody
20-abx135924
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Ovarian Cancer-Related Tumor Marker CA125 (Muc16) Antibody
abx432168-200ul 200 ul
EUR 343.2

Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody
20-abx339194
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody
abx330307-100ul 100 ul
EUR 510

Ovarian cancer with adjacent normal ovary tissue array
OV2001b each
EUR 414
Description: Ovarian cancer with adjacent normal ovary tissue array, including TNM, clinical stage and pathology grade, 200 cases/200 cores, replacing OV2001a

Ovarian cancer with adjacent normal ovary tissue array
OV241d each
EUR 66
Description: Ovarian cancer with adjacent normal ovary tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing OV241c

Ovarian cancer with adjacent normal ovary tissue array
OV242a each
EUR 66
Description: Ovarian cancer with adjacent normal ovary tissue array, including TNM and pathology grade, 12 cases/24 cores (core size 1.5mm), replacing OV242

Ovarian cancer with adjacent normal ovary tissue array
OV242b each
EUR 66
Description: Ovarian cancer with adjacent normal ovary tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing OV242a

Ovarian cancer with adjacent normal ovary tissue array
OV801a each
EUR 270
Description: Ovarian cancer with adjacent normal ovary tissue array, including pathology grade, TNM and clinical stage, 77 cases/80 cores, replaced by OV801b

Human ovarian cancer marker-CA125(CA125)ELISA Kit
YLA1446HU-48T 48T
EUR 435

Human ovarian cancer marker-CA125(CA125)ELISA Kit
YLA1446HU-96T 96T
EUR 562.5

Ovarian cancer tissue array with adjacent normal tissue
BC11115d each
EUR 258
Description: Ovarian cancer tissue array with adjacent normal tissue, including pathology grade, TNM and stage, 100 cases/100 cores, replacing BC11115c

Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody (HRP)
20-abx108512
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Human Ovarian cancer- related protein 1, OCR1 ELISA KIT
ELI-23518h 96 Tests
EUR 988.8

Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody (FITC)
20-abx107091
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody (Biotin)
20-abx105674
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Ovarian cancer with normal tissue survey array (1 of 4)
OV20810a each
EUR 546
Description: Ovarian cancer with normal tissue survey array (1 of 4), including pathology grade, TNM and clinical stage, 208 cases/208 cores, replacing OV20810

Human Ovarian cancer- associated gene 2 protein, OVCA2 ELISA KIT
ELI-35544h 96 Tests
EUR 988.8

Rat Ovarian Cancer-Related Tumor Marker CA125 (MUC16) ELISA Kit
abx256757-96tests 96 tests
EUR 904.8

Pig Ovarian Cancer-Related Tumor Marker CA125 (MUC16) ELISA Kit
abx361716-96tests 96 tests
EUR 990
There was no important distinction between the cumulative recurrence incidence curves of the matched teams (P = .319).Laparoscopic surgical procedure for grossly EGC-mimicking AGC is perhaps secure by way of long-term survival final result. After confirming grossly EGC-mimicking AGC within the remaining pathology report, no further surgical procedure is perhaps required.
Tagsantibodies covid antibodies covid 19 antibodies decline antibodies definition antibodies fade antibodies fading antibodies for coronavirus antibodies for coronavirus immunity antibodies immunity study antibodies in blood antibodies in blood test antibodies in saliva antibodies joke antibodies medical meaning antibodies movie antibodies online antibodies test antibodies test covid antibodies test covid 19 antibodies test for coronavirus antibodies test for covid-19 antibodies vs t cells assay kits biology cells and energy biology cells and molecules biology cells definition biology cells notes biology cells parts biology cells pdf biology cells practice test biology cells questions biology cells quiz biology cells quiz 3 biology cells quizlet biology cells review biology cells revision flashcards gcse biology cells revision notes gcse biology cells study biology cells study guide biology cells test biology cells unit biology cells unit test biology cells unit test answers dna dna testing fraud dna testing free online dna testing heritage dna testing kits dna testing kits 2020 dna testing kits for paternity dna testing kits for paternity hair dna testing kits guides dna testing kits/fl dna testing lab dna testing sites dna testing song dna testing while pregnant dna tests dnajlion7 dnajlion7 youtube dnalion7 youtube

Leave a Reply

Your email address will not be published.